BRIEF CURRICULUM VITAE
Consultant-Oncoplastic Breast Surgeon
Dr. Mitchelle Arvind Engineer
Consultant – Oncoplastic Breast Surgeon
Education
M.B.B.S. , M.S. (General Surgery)
HBNI Fellowship in Breast Surgical Oncology
(Tata Memorial Hospital, Mumbai).
Introduction
Dr. Mitchelle A. Engineer is a trained Oncoplastic Breast Surgeon, practicing at HCG Aastha
Cancer Centre, Ahmedabad. She is highly skilled Oncoplastic Breast Surgeon with six years of
experience in treating breast diseases including cancer. She has completed her M.B.B.S. and
M.S. in General Surgery from M.P. Shah Medical College, Jamnagar, Gujarat. She has also done
HBNI(Homi Bhabha National Institute) fellowship in Breast Surgical Oncology from Tata
Memorial Hospital, Mumbai and also served there as a Consultant for a year. With a deep
commitment to personalized care, she charts individualized care plans for her patients based on
their health profiles. In addition to her clinical responsibilities, she is also involved in cancer
research and aims to contribute to the ever-evolving landscape of oncology.
Area of Expertise:
1. Breast cancer
2. Benign breast diseases
3. Gynecomastia
4. Granulomatous Mastitis
5. Mastalgia
6. Genetic Counselling
Surgeries:
⮚ Modified radical mastectomy(MRM)
⮚Breast conservation surgery (BCS)
⮚ Sentinel lymphnode biopsy (Using Dual Tracer technique)
⮚ Breast oncoplastic surgeries (Round Block, Transposition flap, Chest wall perforator
flaps, LD flap, Therapeutic Reduction Mammoplasty etc.)
⮚ Nipple Sparing Mastectomy(NSM)/Skin Sparing Mastectomy(SSM) with Breast
reconstruction procedures (LD flap, LICAP flap, DIEP, TRAM and Implants).
⮚ Chemoport insertion
Publications and Achievements:
1. A Comparative Study on Fine Needle Aspiration Cytological and Histopathological
Findings in Clinically Palpable Breast Lumps. IOSR Journal of Dental and Medical
Sciences (IOSR-JDMS), 19(8), 2020, pp. 09-14.
2. Unique challenges and outcomes of young women with breast cancers from a tertiary
care cancer centre in India. Breast. 2021 Dec;60:177-184.
2. Effectiveness of a Decision Aid Plus Standard Care in Surgical Management Among
Patients With Early Breast Cancer: A Randomized Clinical Trial. JAMA Netw Open.
2023 Oct 2;6(10):e2335941.
3. Level 3 axillary lymph node involvement in post-chemotherapy node-positive breast
cancer patients – A single Institute experience from India.
https://doi.org/10.1016/j.ejso.2023.107480.
4. Contributed to the formation of Tata Memorial Centre Evidence Based Management of
Breast cancer. Indian Journal of Cancer 61(Suppl 1):p S52-S79,
doi: 10.4103/ijc.ijc_55_24
5. 1st prize winner for Oncostem National fellowship for Oral presentation on ‘Level 3
axillary lymph node involvement in post-chemotherapy node-positive breast cancer
patients’ at ABSICON 2023. Also got chance to present the same at the 42nd Congress of
European Society of Surgical oncology 2023 and at the 3rd Indian Cancer Congress
2023.
Memberships:
1) Association of Surgeons of India.
2) Association of Breast Surgeons of India
-> Through various specialized interventions, she strives to optimize health outcomes for her
patients while also equally prioritizing their quality of life.
-> It is her mission to provide comprehensive cancer care accessible to people coming from all
walks of life and promote health equality.
